Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2‐mutant lung cancer
- 8 November 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 144 (4) , 788-801
Abstract
Somatic KEAP1‐NRF2 pathway alterations are frequently detected in both lung adenocarcinomas and squamous cell carcinomas. However, the biological characteristics and molecular subtypes of KEAP1/NRF2‐mutant lung cancer remain largely undefined. Here, we performed a stepwise, integrative analytic and experimental interrogation of primary tumors and cancer cell lines harboring KEAP1 or NFE2L2 (encoding NRF2) gene mutations. First, we discovered that KEAP1/NRF2‐mutant lung cancer presented APOBEC‐mediated mutational signatures, impaired tumor angiogenesis, elevated hypoxic stress and deficient immune‐cell infiltrates. Second, gene expression‐based subtyping revealed three molecular subsets of KEAP1/NRF2‐mutant lung adenocarcinomas and two molecular subsets of KEAP1/NRF2‐mutant lung squamous cell carcinomas, each associated with distinguishing genetic, differentiation, immunological and clinicopathological properties. Third, single‐sample prediction allowed for de novo identification of KEAP1/NRF2‐active tumors within KEAP1/NRF2‐wild‐type samples. Our data demonstrate that KEAP1/NRF2‐mutant lung cancer is a microenvironmentally distinct, biologically heterogeneous, and clinically underestimated disease. These new pathological and molecular insights may accelerate the development of efficacious therapeutic strategies against human malignancies featured by KEAP1‐NRF2 pathway activation.Keywords
Funding Information
- National Natural Science Foundation of China (81802809, 81802734, 81702292, 81672714, 81472537)
This publication has 50 references indexed in Scilit:
- Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective AutophagyMolecular Cell, 2013
- The Involvement ofNRF2in Lung CancerOxidative Medicine and Cellular Longevity, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- A scaling normalization method for differential expression analysis of RNA-seq dataGenome Biology, 2010
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor GrowthMolecular Cancer Therapeutics, 2010
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder CancerGastroenterology, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLOS Medicine, 2006